Home » Topics » Regulatory

Regulatory
RSS

FDA advisory committee deems ACEL-IMUNE safe and effective for use in infants

Nov. 8, 1996

More convenient formulation of Lodine approved

Nov. 8, 1996

IL-2 treatment dramatically effective in AIDS patients

Nov. 8, 1996

MiKasome cleared for clinical trials in HIV-positive patients

Nov. 8, 1996

New, more convenient testosterone transdermal patch submitted for approval

Nov. 1, 1996

Pfizer 5-HT reuptake inhibitor approved in U.S. for new indication

Nov. 1, 1996

Cefzil approved for new indication in U.S.

Nov. 1, 1996

Additional clinical data support the potential of DepoCyt in neoplastic meningitis

Oct. 25, 1996

Sulfasalazine approved for rheumatoid arthritis

Oct. 25, 1996

Expanded indications for Abelcet

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...